Circulating tumor DNA detection in head and neck cancer: evaluation of two different detection approaches
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F17%3A10364612" target="_blank" >RIV/00216208:11110/17:10364612 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.18632/oncotarget.20004" target="_blank" >http://dx.doi.org/10.18632/oncotarget.20004</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.18632/oncotarget.20004" target="_blank" >10.18632/oncotarget.20004</a>
Alternative languages
Result language
angličtina
Original language name
Circulating tumor DNA detection in head and neck cancer: evaluation of two different detection approaches
Original language description
The use of non-invasive biomarkers such as circulating tumor DNA (ctDNA) in head and neck tumors may be of relevance in early diagnosis and eventually improved outcome. We evaluated two different approaches from two case series in Europe and South America including (i) targeted screening of ctDNA mutations, and (ii) detection of TP53 mutations in plasma and oral rinses without previous knowledge of mutational status in tumor samples. Targeted sequencing in 5 genes identified ctDNA mutations in plasma among 42% of HNSCC cases, 67% of who were early stage cases. No association was found between ctDNA mutation detection and overall survival. Sequencing of the entire coding region of the TP53 gene resulted in identification of TP53 mutations in 76% of tumor cases. However, concordance of mutation detection was low between tumor, oral rinses (11%) and plasma (2,7%) samples. Identification of 5 pathogenic TP53 mutations in oral rinses from 3 non-cancer controls gives additional evidence of mutation occurrence in individuals without a diagnosed cancer and presents an additional challenge for the development of ctDNA diagnostic assays.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
—
Continuities
V - Vyzkumna aktivita podporovana z jinych verejnych zdroju
Others
Publication year
2017
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Oncotarget
ISSN
1949-2553
e-ISSN
—
Volume of the periodical
8
Issue of the periodical within the volume
42
Country of publishing house
US - UNITED STATES
Number of pages
12
Pages from-to
72621-72632
UT code for WoS article
000411509400102
EID of the result in the Scopus database
—